These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38640585)

  • 1. Health-related quality of life and utilities among Lebanese patients with Multiple Sclerosis: A cross-sectional study.
    Dahham J; Hiligsmann M; Kremer I; Khoury SJ; Darwish H; Hosseini H; Hallit S; Evers S; Rizk R
    Mult Scler Relat Disord; 2024 Jun; 86():105635. PubMed ID: 38640585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand.
    Claflin S; Campbell JA; Norman R; Mason DF; Kalincik T; Simpson-Yap S; Butzkueven H; Carroll WM; Palmer AJ; Blizzard CL; van der Mei I; Henson GJ; Taylor BV
    Eur J Health Econ; 2023 Aug; 24(6):939-950. PubMed ID: 36149605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient characteristics and determinants of quality of life in an international population with multiple sclerosis: assessment using the MusiQoL and SF-36 questionnaires.
    Fernández O; Baumstarck-Barrau K; Simeoni MC; Auquier P;
    Mult Scler; 2011 Oct; 17(10):1238-49. PubMed ID: 21669936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in utility scores obtained through Brazilian and UK value sets: a cross-sectional study.
    Takemoto ML; Lopes da Silva N; Ribeiro-Pereira AC; Schilithz AO; Suzuki C
    Health Qual Life Outcomes; 2015 Aug; 13():119. PubMed ID: 26246238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Economic and societal burden of multiple sclerosis on lebanese society: a cost-of-illness and quality of life study protocol.
    Dahham J; Rizk R; Hiligsmann M; Daccache C; Khoury SJ; Darwish H; Evers S; Kremer I
    Expert Rev Pharmacoecon Outcomes Res; 2022 Jul; 22(5):869-876. PubMed ID: 34826264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression, fatigue and disability are independently associated with quality of life in patients with multiple Sclerosis: Results of a cross-sectional study.
    Schmidt S; Jöstingmeyer P
    Mult Scler Relat Disord; 2019 Oct; 35():262-269. PubMed ID: 31437741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The societal costs of multiple sclerosis in Lebanon: a cross-sectional study.
    Dahham J; Hiligsmann M; Kremer I; Khoury SJ; Darwish H; Hosseini H; Evers S; Rizk R
    Expert Rev Pharmacoecon Outcomes Res; 2023 Apr; 23(4):419-430. PubMed ID: 36820619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of illness in multiple sclerosis (DEFENSE) study: the costs and quality-of-life of Finnish patients with multiple sclerosis.
    Ruutiainen J; Viita AM; Hahl J; Sundell J; Nissinen H
    J Med Econ; 2016; 19(1):21-33. PubMed ID: 26360615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran.
    Pakdaman H; Amini Harandi A; Gharagozli K; Abbasi M; Tabassi A; Ashrafi F; Ghaffarpor M; Sharifi S; Delavar Kasmae H; Assarzadegan F; Arabahmadi M; Behnam B
    Int J Neurosci; 2017 Jun; 127(6):501-507. PubMed ID: 27279451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS).
    Achtnichts L; Zecca C; Findling O; Kamm CP; Mueller S; Kuhle J; Lutterotti A; Gobbi C; Viviani C; Villiger-Borter E; Nedeltchev K
    BMJ Neurol Open; 2023; 5(1):e000304. PubMed ID: 36727105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsiveness of the Multiple Sclerosis International Quality of Life questionnaire to disability change: a longitudinal study.
    Baumstarck K; Butzkueven H; Fernández O; Flachenecker P; Stecchi S; Idiman E; Pelletier J; Boucekine M; Auquier P
    Health Qual Life Outcomes; 2013 Jul; 11():127. PubMed ID: 23895207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quality of life assessment in patients with multiple sclerosis].
    Tepavcević DK; Pekmezović T; Drulović J
    Vojnosanit Pregl; 2009 Aug; 66(8):645-50. PubMed ID: 19780420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health Utilities for Multiple Sclerosis.
    Hawton A; Green C
    Value Health; 2016 Jun; 19(4):460-8. PubMed ID: 27325338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of disease, functional status, and relapses on the utility of people with multiple sclerosis in the UK.
    Orme M; Kerrigan J; Tyas D; Russell N; Nixon R
    Value Health; 2007; 10(1):54-60. PubMed ID: 17261116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life of patients with multiple sclerosis and neuromyelitis optica spectrum disorders: Cross-sectional and longitudinal analysis.
    Kim S; Lee EJ; Kim KW; Seo D; Moon S; Kim KK; Lim YM
    Mult Scler Relat Disord; 2022 Feb; 58():103500. PubMed ID: 35032884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs and quality of life of multiple sclerosis in Sweden.
    Berg J; Lindgren P; Fredrikson S; Kobelt G
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S75-85. PubMed ID: 17310342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs and quality of life in multiple sclerosis in The Netherlands.
    Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs and quality of life of multiple sclerosis in Austria.
    Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relating health-related Quality of Life to disability progression in multiple sclerosis, using the 5-level EQ-5D.
    Fogarty E; Walsh C; Adams R; McGuigan C; Barry M; Tubridy N
    Mult Scler; 2013 Aug; 19(9):1190-6. PubMed ID: 23401128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis?
    Kuspinar A; Mayo NE
    Health Qual Life Outcomes; 2013 Apr; 11():71. PubMed ID: 23618072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.